Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
Alice O. Kamphorst(Icahn School of Medicine at Mount Sinai), Suresh S. Ramalingam(Emory University), Rafi Ahmed(Emory University), Gabriel Sica(Emory University), Lydia Koenig(Emory University), Zhengjia Chen(Hunan University of Traditional Chinese Medicine), Fadlo R. Khuri(American University of Beirut Medical Center), Chao Zhang(Sun Yat-sen University), Andreas Wieland(Emory University), Tahseen H. Nasti(Emory University), Megan McCausland(Emory Healthcare), Rama Akondy(Emory University), Ke Yu(Emory University), Hong Wu(Shanghai Tenth People's Hospital), Shu Yang(Central South University), Nikita Patel(Emory University), Madhusmita Behera(National Institutes of Health), Rathi N. Pillai(Emory University), Taofeek K. Owonikoko(UPMC Hillman Cancer Center)
Cited by 899
Related Papers
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
Genomic Classification of Cutaneous Melanoma
|Cell|2015|3.3k
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k